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ABSTRACT
Objective: The objective of the study was to look on the prevalence of six AMR genes (CTX-M, TEM, SHV, NDM-1, OXA-48, and VIM genes) in the 
province of the Arabian Gulf. We performed a systematic review and meta-analysis of the published studies from the Arabian Gulf countries and 
analyzed the antimicrobial resistance (AMR) genes pattern present in Klebsiella pneumoniae.
Methods: The present study used the Meta-analysis Of Observational Studies in Epidemiology as a guideline for reporting findings. An electronic 
search was conducted in online databases such as PubMed/MEDLINE, EMBASE, Scopus, Google Scholar, Science Direct, and Web of Science from 
January 2014 to June 2020 following the inclusion and exclusion criteria. Articles published were included in the study resistance pattern among 2036 
isolates were analyzed. These isolates conferred the AMR genes including OXA-48 (n=500), CTX-M (n= 1796), SHV (n=1637), TEM (n=1492), NDM-1 
(n=500), and VIM (n=302).
Results: Of 160 initially searched studies, 28 entries met the inclusion criteria and were subjected to meta-analysis. Critical appraisal of studies or 
quality assessment revealed a mean quality score was 4.2, with an SD of 1.6. The analysis revealed predominant AMR genes wereOXA-48 followed by 
CTX-M, SHV, TEM, NDM-1, and VIM in the Arabian Gulf region.
Conclusion: The Arabian Gulf countries share a high prevalence of OXA-48, CTX-M followed by SHV, TEM, NDM-1, and VIM genes. Antimicrobial-
resistant in K. pneumoniae is a threat to public health and this needs strong surveillance to curb this threat.
Keywords: Antimicrobial resistance genes, Arabian Gulf region, Klebsiella pneumoniae, Meta-analysis, Systematic review.
INTRODUCTION
Klebsiella is one of the common pathogens causing community-
acquired bacterial pneumonia, urinary tract infection, and septicemia 
in patients. If untreated, it can lead to a high mortality rate [1,2]. 
A vast majority of Klebsiella infections are hospital-acquired. 
Individuals with underlying diseases such as diabetes mellitus or 
chronic pulmonary obstruction or other immunocompromised states 
can acquire Klebsiella as a nosocomial infection [1]. In fact, Klebsiella 
has been reported as the second most common cause of bacteremia in 
patients with burns [3].
It is a challenge to treat Klebsiella clinically. Bacteria have developed 
effective defense mechanisms against most of the antibiotics [4]. 
Multidrug resistance is reported in Klebsiella since 1984 [3]. Klebsiella 
has become resistant to beta-lactam drugs, including cephalosporins 
and aminoglycosides due to its ability to encode extended-spectrum 
β-lactamases (ESBLs) and aminoglycoside modifying enzymes [3]. An 
increase in antimicrobial resistance (AMR) in Klebsiella pneumonia 
isolates is of much concern.
The CDC estimates that within the United States, quite 2 million people 
are diseased with antibiotic-resistant microorganisms annually. Among 
them, around 23,000 die every year [5]. Several factors can contribute 
to the spread of AMR, including inappropriate antibiotic use in the 
health-care sectors and agriculture and lack of new antimicrobial 
therapeutics [5,6]. Continuous exposure of bacterial strains to multiple 
β-lactam drugs has induced dynamic and continuous production and 
mutation of β-lactamases. It has even increased its activity against the 
newly developed β-lactam antibiotics which are known as ESBLs [7]. 
The occurrence of ESBL producing Enterobacteriaceae is also reported 
in human and veterinary medicine [8].
Several studies have addressed increased AMR rates among bacterial 
organisms in the Arabian Gulf Region. They have reported multiple 
factors that might be contributing to the increasing AMR rates [9].
The prevalence of AMR genes has severe implications for the future 
therapy and prevention of infectious diseases in humans. Studies have 
identified multiple genes to be associated with AMR in the Arabian Gulf 
region. However, there are no comprehensive reviews of these studies. 
This article aims to review the occurrence of six AMR genes (CTX-M, 
TEM, SHV, NDM-1, OXA-48, and VIM genes) in the Arabian Gulf region. 
We conducted a systematic review and meta-analysis of the studies 
reporting the presence of AMR genes in K. pneumoniae, published from 
the Arabian Gulf region.
METHODS
The present study used the “Meta-analysis Of Observational Studies in 
Epidemiology (MOOSE)” guidelines for reporting findings [10].
Database searches 
We conducted an electronic search in seven online databases 
PubMed/MEDLINE, EMBASE, Scopus, Google Scholar, Science 
Direct, and Web of Science for articles published between January 
2014 and September 2019. The search strategy included relevant 
keywords: “Klebsiella pneumoniae” OR “Enterobacteriaceae” OR 
“antimicrobial resistance” OR “antibiotic resistance” OR “drug-
resistance” OR “Eastern Mediterranean” OR “The Middle East” OR 
“antimicrobial resistance” OR “antibiotic resistance” OR “drug-
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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resistance” OR “Gulf Co-operation Council (GCC)” OR “Saudi Arabia 
(KSA)” OR “Bahrain” OR “Kuwait” OR “Oman” OR “United Arab 
Emirates (UAE)” OR “Qatar” OR “resistant genes” AND “Extended-
Spectrum Beta-Lactamase (ESBL)” OR “Metallobeta-lactamase 
(MBL)” OR “CTX-M” OR “NDM-1 OR “OXA-48” OR “TEM” OR “VIM” 
OR “SHV.”
Two authors independently reviewed the titles and abstracts and chose 
those fitting the selection criteria for full-text evaluation and excluded 
irrelevant publications. Any discrepancies regarding study eligibility 
were discussed with other authors to reach a consensus. To standardize 
data extraction, the reviewers collected data for study characteristics 
(e.g., type of bacterial isolates, country, year, sample size, and type of 
antibiotic-resistant genes). Extracted data were entered into Microsoft 
Excel Sheet for analysis. 
Inclusion criteria
We included observational studies and intervention studies reporting 
the presence of any of the selected six AMR genes in clinical strains of 
K. pneumoniae.
Inclusion criteria for study selection were:
•	 All original research articles published in the English language
•	 Publication date between January 2014 to June 2020
•	 Studies that included K. pneumoniae clinical isolates
•	 Studies that reported AMR genes from Arabian Gulf countries.
•	 Articles reporting resistant genes detection by molecular methods 
(PCR).
Exclusion criteria
The following criteria were excluded from the study:
•	 Studies conducted on K. pneumoniae strains from environmental 
resources such as food, water, and air
•	 Studies reporting secondary data
•	 Studies on other AMR genes that are not included in the selection 
criteria
•	 Studies reporting resistance genes by phenotypic methods
•	 Case reports, short communications, abstracts, review articles, 
editorials, and non-English-language articles
•	 Unpublished, non-peer-reviewed data, all of which were excluded 
from the quantitative and qualitative analysis.
If more than one article is published from a single study, the results are 
combined, and the studies are considered only once for analysis. The 
flow diagram of study selection is shown in Fig. 1.
Primary outcome
The primary outcome of this review is the prevalence of six AMR genes 
(CTX-M, NDM-1, OXA-48, TEM, VIM, and SHV) in Klebsiella isolates from 
patients in the Arabian Gulf region.
Critical appraisal of studies (quality assessment)
Two reviewers independently assessed the methodological quality of 
studies using a standardized checklist consisting of six items. The items 
included sample size, sampling technique, standardization of data 
collection, appropriateness of statistical analyses, quality of reporting 
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and six were given. A score of 0–2 corresponds to low quality, 3–4 to 
medium quality, and 5–6 to high quality. If there was a discrepancy, the 
quality score was assigned for each study by consensus of all authors 
after discussion with the principal investigator. We used the Newcastle-
Ottawa Scale as a guide for assessing the quality of nonrandomized 
studies in meta-analysis [11].
Statistical analysis and reporting
We performed a series of single-group analysis based on sample size 
and event rate. We used Random-effects modeling in the analysis. 
Using random-effects modeling, we, therefore, assume that there is not 
only one true effect size, instead, a distribution of true effect sizes. We, 
therefore, sought to estimate the mean of the distribution of true effect 
sizes. Moderator analysis was performed on the variable country and 
was performed using subgroup analyses. All statistical analyses were 
performed using the Comprehensive Meta-Analysis version 3.0.
RESULTS
Of 160 initially searched studies, 28 entries met the inclusion criteria 
and were subjected to a meta-analysis [12-38]; the stages of evaluation 
and exclusion of the identified studies were as per the inclusion chart 
is presented in Fig. 1. Study characteristics (e.g., authors, country, year, 
sample size, patient location, and type of antibiotic-resistant genes) are 
represented in Table 1.
Critical appraisal of studies or quality assessment revealed mean 
quality score was 4.2, with an S.D. of 1.6; indicating that studies were 
generally of medium quality.
The most common resistance genes reported are OXA-48, followed 
by CTX-M, SHV, TEM, NDM-1, and VIM. The prevalence of OXA-
48 is 61.3% and CTX M is 49.9%, followed by SHV (46.1%), TEM 
(32.5%), NDM-1 (26.9%), and VIM (6.1%). Detailed results of the 
point estimate, the 95%CI, and measures of heterogeneity are 
shown in Table 2. Forest plots of the meta-analysis are presented 
in Figs. 2-7.
Subgroup analysis 
The subgroup analysis of the different AMR genes was conducted by 
country in which studies were done (Fig. 2-7). As can be seen, by the 
forest plots, OXA- 48 gene was studied exclusively in Saudi Arabia. 
Of the eight studies that have studied the OXA-48 gene, six of them 
reported point prevalence of the gene to be more than 0.5%. The mean 
point prevalence was 65.1% (Fig 2).
CTX-M gene was studied by two studies from Kuwait, studies from 
Qatar, 15 studies from Saudi Arabia, and two studies from UAE. The 
prevalence of the gene was highest in UAE (93.6%), followed by Kuwait 
(56.4%) and Saudi Arabia (49.1%). Studies from Qatar reported the 
least prevalence (6.6%) (Fig 3).
SHV gene was also studied by all four countries. Thirteen studies 
were from Saudi Arabia, while two studies were from each of UAE, 
Kuwait, and Qatar. The point prevalence of the gene was similar in 
distribution to the CTX-M gene with maximum prevalence in UAE 
(85.2%), followed by Kuwait (59.1%), Saudi Arabia (46.8%), and 
Qatar (7.7%) (Fig. 4).
Table 1: Study characteristics
Authors Country Patient location Sample size OXA‑48 CTX ‑M SHV TEM NDM‑1 VIM
Al-Qahtani et al. (2014) [19] Saudi Arabia Hospital 98 32 34 20
Jamal et al. (2013) [16] Kuwait Medical and surgical 
ward, ICU
9 4 7 5 3 6
Jamal et al. (2016) [31] Kuwait Public hospitals 14 9 6 14
Al-Zahrani et al. (2018) [12] Saudi Arabia Province hospitals 54 44 4 1
AlTamimi et al. (2017) [13] Saudi Arabia Inpatients and 
outpatients
34 18 4 1
Shibl et al. (2013) [14] Saudi Arabia Inpatients 60 47 37 39 17 12 1
Sonnevend et al. (2015) [15] Arabian Peninsula Inpatients 145 43 78 6
Eltai et al. (2018) [17] Qatar Pediatric patients 13 0 0 0
Elhassan et al. (2016) [18] Saudi Arabia Inpatients and 
outpatients
359 6 9 8
Alsultan et al. (2013) [20] Saudi Arabia Inpatients and 
outpatients
37 0 29 16
Ahmed et al. (2016) [21] Qatar ICU 629 42 49 30
Alfaresi et al. (2018) [22] United Arab Emirates General Hospital 5 5 4 5
Alzahrania et al. (2017) [23] Saudi Arabia Inpatients 3 3 2
Hassan et al. (2013) [24] Saudi Arabia Inpatients and 
outpatients
90 82 77 43
Leangapichart et al. (2016) [25] Saudi Arabia Adults 1 1
Leangapichart et al. (2016) [25] Saudi Arabia Adults 5 5 4 4
Soliman et al. (2018) [26] Saudi Arabia Inpatients and 
outpatients
33 13 12 0
Somily et al. (2015) [27] Saudi Arabia Inpatients and 
outpatients
27 23 16 1
Sonnevend et al. (2017) [28] United Arab Emirates Adult 9 9 8 8
Uz Zaman et al. (2014) [29] Saudi Arabia Patients 23 23 23 23 22
Alsheikh et al. (2014) [30] Saudi Arabia Patients 92 9 0 44
Al-agamy et al. (2013) [32] Saudi Arabia Patients 9 7 8 9 2
Zowawi et al. (2014) [33] Saudi Arabia Hospital 147 34 48 10
Alotaibi et al. (2017) [34] Saudi Arabia Inpatients 5 1 3
Al-Agamy et al. (2018) [35] Saudi Arabia Hospitals 21 14 19 7
Ahn et al. (2015) [36] United Arab Emirates ICU 2 2 0
Shahid (2014) [37] Bahrain Adult patients 5 5
Hassan (2014) [38] Saudi Arabia Hospital 107 9 3
*Empty field: Not reported, ICU: Intensive care unit
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There were no studies on the TEM gene from Kuwait. There were 
two studies from each of Qatar and UAE while 11 studies were 
from Saudi Arabia. The prevalence of the gene was highest in the 
UAE (89.9%), while it was 30.5% in Saudi Arabia and 4.7% in Qatar 
(Fig. 5).
Two studies from Kuwait and seven studies from Saudi Arabia 
studied the NDM-1 gene. The point prevalence of the gene was 
75.5% in Kuwait. However, the studies differed significantly in their 
estimation of the prevalence, and the mean confidence interval was 
broad. Studies from Saudi Arabia reported a prevalence of 4.7% 
(Fig. 6).
VIM gene was studied exclusively in Saudi Arabia. Only three studies 
reported studying the VIM gene. The mean point prevalence of the gene 
was 2.1% (Fig. 7).
DISCUSSION
K. pneumoniae is a pathogen known for its resistance to most 
of the antibiotics used. The increasing trends in the isolation of 
antimicrobial-resistant K. pneumoniae are of much concern [6]. K. 
pneumoniae have acquired carbapenemases, which are capable of 
breaking down most β-lactams, including carbapenems, and confer 
resistance to these drugs. Reports indicate that carbapenemase-
Table 2: Prevalence of antimicrobial resistance genes
Parameters OXA‑48 CTX‑M SHV TEM NDM‑1 VIM
Number of studies (K) 10 22 19 16 11 5














Q-value 102.938 416.089 418.179 265.348 93.550 28.150
Df (Q) 9 21 18 15 10 4
p 0.000 0.000 0.000 0.000 0.000 0.000
I2 91.257 94.953 95.696 94.347 89.311 85.790
Tau2 1.330 2.869 3.475 2.318 1.627 3.475
CI: Confidence interval, Q-value: Cochran’s Q, Df: A degree of freedom, I2: A measure of variability between studies, P: P value, Tau2: Variance of the two effect sizes
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producing Enterobacteriaceae isolates are increasing in number in 
the last few years [39].
In this study, the OXA-48 (61.3%) is seen to be the most 
predominant antimicrobial gene in the Arabian Gulf Region. 
OXAKp isolates are detected worldwide. The first description of 
isolates with OXA-48 like genes was reported in 2013 in the United 
States [40]. A study from China has reported 14.9% of the clinical 
isolates of K. pneumoniae with OXAKp [41]. In a study from India, 
significantly, 80% of their isolates were blaOXA-232 producers 
[42]. A study from Turkey reported 86% of their isolates harbored 
the OXA-48 gene [43]. The high prevalence of OXA-48 in the 
Arabian Gulf reflects the extensive flow between the countries of 
the Middle East and endemic countries including Turkey, India, 
and Pakistan[12]. 
CTX-M enzymes are Class A ESBLs that are spreading rapidly 
among Enterobacteriaceae worldwide [44]. In our study analysis, 
the CTX-M gene (49.9%) was the next predominant gene persistent 
in clinical isolates. No CTX-M was detected in the U.S. before 2000 
among ESBL-producing K. pneumoniae isolates, with all CTX-M–
producing K. pneumoniae isolates recovered from U.S. patients 
in or after 2004 [45]. The emergence and spread of CTX-Min K. 
pneumoniae have evolved recently in the mid to late 2000s in 
the United States. To date, CTX-M-producing K. pneumoniae has 
been recognized in several U.S. states, including Texas, Nebraska, 
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Pennsylvania, California, Massachusetts, Michigan, New Jersey, 
New York, Washington, and Wisconsin [46]. Jemima and Verghese 
reported the presence of CTX-M genes in 40% of Klebsiella spp. 
[47]. Another study in India by Sekar et al. reported the prevalence 
of the CTX-M gene in 35.89% of Gram-negative isolates [48]. The 
presence of the CTX-M gene is worrisome as the plasmids carrying 
this determinant has also the ability to seize other resistance 
determinants, including carbapenemases genes [49], and thus 
spread multidrug resistance.
In the present analysis, the SHV gene was present in 46.1%, TEM in 
32.5%, and the carbapenem-resistant genes – NDM-1 in 26.9% and 
VIM in 6.1% of the total studies. Al-Qahtani et al. in Saudi Arabia 
reported the presence of SHV-12 (29.73%) and SHV-5 (5.4%) and 
TEM (54.05%). A study in Kuwait observed a high prevalence of VIM-
4 (66.6%), followed by NDM-1 (33.3%) and SHV-11 (55.5%), SHV-
31 (11.1%), and SHV-26 (11.1%). Interestingly, they also reported 
OKP type in K. pneumoniae which is a variant of naturally occurring 
SHV-type enzymes. This suggests wide dissemination of the genes 
throughout Arabian countries [16]. Some studies have reported 
the co-existence of MBLs and ESBLs in the enterobacterial isolates 
[16,50]. Treatment of patients infected with these multi-resistant 
infectious agents is challenging.
Globally, Greece has the highest rate of reported carbapenem 
resistance (68%) followed by India and eastern Mediterranean 
regions with 54% resistance. USA (11%), China (11%), and Africa 
(4%) have the lowest resistance rates, respectively [40]. Dehshiri et 
al. in Iran demonstrated the presence of the genes TEM (16.1%), and 
SHV (85.5%) among the K. pneumoniae isolates from urine samples 
[51], while in India, among the ESBLs, SHV, TEM, and CTX-M have 
been commonly reported by Veeraraghavan et al. [52]. In China, 
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Zhang et al. reported NDM-1 producing K. pneumoniae isolates in 
the neonatal ward of a teaching hospital [53]. Liu et al. reported four 
diverse types (NDM-1, KPC-2, VIM-2, and IMP-4) of carbapenemase 
of K. pneumoniae clones in a single hospital in China [54]. The VIM 
gene is extensively distributed worldwide, with VIM-2 the most 
widespread variant. VIM enzyme endemicity has been reported 
in Greece, Taiwan, and Japan, and outbreaks and single strains of 
VIM producers have been stated in many other countries including 
México, Argentina, Colombia, and Venezuela [55]. VIM-1-producing 
Enterobacteriaceae have been associated with single cases, small 
outbreaks, or polyclonal spread affecting different species of bacteria 
in Spain [11].
As can be seen from the subgroup analysis, the maximum number of 
studies was conducted in Saudi Arabia, while the other three countries 
had near equal representation. Some genes (OXA-48 & VIM) were 
studied exclusively in Saudi Arabia. One of the reasons for the same 
can be the country size and the drive for research. The population of 
Saudi Arabia is nearly 16 times that of Qatar, more than 8 times Kuwait, 
and more than 3 times the population of the UAE. Furthermore, Saudi 
Arabia is a forerunner in the research front and has an active and 
zealous research community. This might have manifested in maximum 
representation from the country.
However, all four countries are in geographic continuity and share 
similar demography, environment, disease epidemiology, and even 
cultural practices. The differences observed in the prevalence of 
different AMR genes might be due to the differences in the number 
of studies and the sample sizes than true prevalence. For the same 
reason, the results of the study can be generalized to other gulf 
countries.
Overall, Arabian Gulf Countries are more susceptible to multidrug 
infections including carbapenem-resistant genes. This is mainly due 
to the high resident expatriate population (average 48%), extensive 
international links, lack of clear guidelines on antimicrobial use, and 
deficiency of policies for containing and reviewing antimicrobial 
prescriptions [15].
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Fig. 7: Klebsiella VIM gene. (a) Meta‑analysis results. (b) 
Subgroup (by country) meta‑analysis results
United Arab Emirates, Oman, and Qatar, have been critically reviewed 
in this study. These countries share a high prevalence of OXA, CTX-M 
followed by SHV, TEM, NDM, and VIM genes. Antimicrobial-resistant 
in K. pneumoniae is a threat to public health, and this needs robust 
surveillance to curb this menace. Health-care sectors need to monitor 
and report changes in antimicrobial-resistant isolates. A multifactorial 
approach, including standard guidelines, and appropriate infection 
control measures is necessary to curb this threat.
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